Study: Latent Hepatitis C Infection Can Lead to Stroke; polyDNA Recommends Muxscle Against the Latent HCV

A study published on November 12, 2013 in PLoS One found that “chronic HCV infection is an independent risk factor of stroke or cerebrovascular death (1).” polyDNA recommends Muxscle to help target the latent HCV.

Most doctors do not address the possibility that a latent virus can cause a stroke. By ignoring the virus, they put their patient at risk. - polyDNA

Rochester, NY (PRWEB) December 19, 2013

In 2012, the Reuters news agency reported that “Hepatitis C (HCV) has surpassed HIV as a killer of U.S. adults…” in an article published on February 23 (2). Studies show that HCV kills adults in more ways than one. One way is by stroke. “Increased evidence indicates that acute and various chronic infectious diseases are important triggers of or risk factors for stroke (1).” Specifically, the latent HCV increases plaques in the brain. As study authors wrote, “chronic HCV infection increased the risk of ultrasonographically defined carotid intima-media thickness (the wall of the arteries) and or plaque (residue attached to the artery wall), which are predictors of cerebrovascular (blood vessels in the brain) disease (1).” In addition, “It was also found that HCV replicated with carotid plaque (1).”

These are not the only ways that latent HCV can lead to a stroke, however, “HCV infection also increased the risk of metabolism diseases, such as type II diabetes (1).” “Conventional risk factors for stroke include cardiac (heart) diseases, hypertension, diabetes, smoking, alcohol consumption, unhealthy diet, abdominal obesity, lack of exercise, psychosocial stress, and depression (1).” All of these events, in connection with HCV, increase the risk of stroke.

“Recent research has shown that chronic and/or past infections increase the risk of stroke. We feel it’s time for doctors to begin targeting latent viruses, which is the underlying cause of stroke.” -Mike Evans, polyDNA.

As mentioned in Mr. Evan’s comments, several studies have shown that “chronic and/or past infections rather than any one single infectious disease is associated with the risk of stroke.” This is according to a study published on December 6, 2010 in Nature Reviews, Neurology (3).

“The effects of stroke vary from person to person based on the type, severity, and location of the stroke. The brain is extremely complex and each area of the brain is responsible for a special function or ability. When an area of the brain is damaged, which typically occurs with a stroke, impairment may result.” (Ohio State University, Wexner Medical Center) (4)

Most doctors do not address the possibility that a latent virus can cause a stroke. By ignoring the virus, they put their patients at unnecessary risk.

polyDNA recommends Muxscle, an antiviral natural product designed to be effective against latent viruses. Each capsule of Muxscle contains a patented formula of five all natural ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum extract, and licorice extract. In addition, each bottle is GMP Certified.

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery called Microcompetition with Foreign DNA.

The discovery explains how foreign DNA fragments and specifically DNA of latent viruses cause most major diseases. polyDNA developed Muxscle, an antiviral natural remedy that helps the immune system kill latent viruses and prevent secondary stroke.